in the gross profit margin that expanded from 15.3% in the third quarter of 2018 to 16.4% in the third quarter of 2019 and more efficient cost management that caused selling and administrative expense
THB 40.7 million or 24.9% and gross profit margin to total revenues was at 15.0%. The Group reported total net profit for the year 2017 at THB 50.4 million, decreased by THB 32.9 million or 39.5% when
Instruments which came into force on January 1, 2020. Nonetheless, net interest income and net interest margin (NIM) rose over-quarter due to loan growth and the TFRS9 revenue recognition concept in which
เช่น พันธบัตร หุ้นกู้ ตั๋วสัญญาใช้เงิน บัตรเงินฝาก Letter of Credit และ Letter of Guarantee เป็นต้น 3. เงินให้กู้ยืมคงค้าง (margin loan) จำนวนเงินที่ลูกค้ากู้ยืมจากบริษัทหลักทรัพย์เพื่อซื้อหลักทรัพย์ 4
same period of 2017, due to the increasing of the quantity of Sales by 17%. 2. Cost of goods sold was Baht 1,275.68 million which the gross profit margin was decreased to 10.06% when compare to the same
115.40% Gross profit margin 61.51% 59.98% 1.53% Net profit margin 45.50% 36.59% 8.91% บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2
THB 13.4 million or 10.9% and gross profit margin to total revenues was at 15.4%. The Group reported total net profit for the year 2018 at THB 20.6 million, decreased by THB 29.8 million or 59.1% when
154.18 Administration expense 15.89 11.98 30.99 19.01 158.76 15.10 94.99 Net Profit -0.97 13.76 30.91 17.15 124.66 31.88 1,643.30 Gross Profit Margin (%) 5.61 20.08 18.04 -2.04 -10.18 12.43 221.57 Net
-18.38 -68.27 5.18 154.18 Administration expense 15.89 11.98 30.99 19.01 158.76 15.10 94.99 Net Profit -0.97 13.76 30.91 17.15 124.66 31.88 3,286.60 Gross Profit Margin (%) 5.61 20.08 18.04 -2.04 -10.18